A Bioterror Risk-Assessment Methodology

Although numerous scientists and stakeholders recognize a need for increased security measures at microbiological laboratories, Richard Gallagher speaks for many by asking, "Is it possible that we could have a more measured public debate? A more objective assessment of the threat?"1We contend that biosecurity measures at bioscience institutions should be based on an intellectually defensible risk-assessment approach, which evaluates the probability and consequences that biological material would

Written bySusan Rivera
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Although numerous scientists and stakeholders recognize a need for increased security measures at microbiological laboratories, Richard Gallagher speaks for many by asking, "Is it possible that we could have a more measured public debate? A more objective assessment of the threat?"1

We contend that biosecurity measures at bioscience institutions should be based on an intellectually defensible risk-assessment approach, which evaluates the probability and consequences that biological material would be maliciously stolen and used as a biological weapon. We believe that this approach would accomplish at least three important goals: 1) help prioritize the various security risks associated with biological materials; 2) help determine how best to protect against those risks; and 3) help establish a credible rationale for an appropriate level of biosecurity.

Under current US regulations, everything listed as select agents must legally be protected by the same security measures, but most experts agree that Bacillus anthracis has greater ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies